Home / Inspections / 1116968

FDA Inspection 1116968 — Shire Human Genetic Therapies, Inc.

Shire Human Genetic Therapies, Inc. — FEI 3009340644

The FDA completed an inspection of Shire Human Genetic Therapies, Inc. on January 15, 2020 in Lexington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 15, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, MA (United States)

Facility

Other inspections at this facility

  • 1297340 (VAI Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1167818 (VAI Fri Apr 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1061705 (VAI Wed Jul 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004081 (VAI Fri Jan 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982412 (NAI Thu Jul 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources